đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
This study is designed to evaluate in a controlled manner the effect of Pre...
Status
Completed
Location
Multiple Locations
Start Date
2003-10
Trial ID
NCT00772928
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
Objectives: * To present the rates of adverse reactions after a dose of DA...
Status
Completed
Location
Multiple Locations
Start Date
2004-02
Trial ID
NCT00802867
Treatments Being Tested
This study was designed to assess the lot comparability of DAPTACEL, as wel...
Status
Completed
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT00662870
The purpose of this study is to evaluate the safety, tolerability, and immu...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0159)
Start Date
2019-06-19
Trial ID
NCT03893448
Treatments Being Tested
Primary Objectives: 1. To present the safety profile after a 5th dose of D...
Status
Completed
Location
Multiple Locations
Start Date
2005-03
Trial ID
NCT00258895
Treatments Being Tested
The purpose of this study is to evaluate the safety, tolerability and immun...
Status
Completed
Location
Multiple Locations
Start Date
2001-05
Trial ID
NCT00551915
Treatments Being Tested
The purpose of this study is to evaluate safety, to demonstrate lot-to-lot ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-18
Trial ID
NCT01000974
The goal of this study is to evaluate the safety, tolerability, and immunog...
Status
Completed
Location
Alabama Clinical Therapeutics ( Site 0015)
Start Date
2018-10-18
Trial ID
NCT03620162
Treatments Being Tested
PR5I, a hexavalent pediatric combination vaccine is being developed to redu...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00362427